Ranbaxy sets up another manufacturing unit in South AfricaIllustrative image – not actual.

Ranbaxy Laboratories has set up a new manufacturing facility in South Africa.

The new unit has been set up at an investment of $30 million (approx Rs 139.5 crore). It has the capacity to produce approximately 1.75 billion units per annum and packaging of two billion units per annum of drugs.

The plant manufactures analgesics, cold, cough and flu preparations, anti-histamines, anti-hypertensive, central nervous system drugs, vitamins and minerals as well as a comprehensive range of over-the-counter medication. The products manufactured are to comprise tablets and hard gelatin capsules which are likely to be supplied to current registered regions.

The company's new facility is the second manufacturing unit in South Africa and the third in the African continent after Nigeria.

← All latest storiesBack to top →